Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|August 25, 2012
Giant adrenal angiomyolipomaHonglin Hu, Xiaoqing Xi
Frontiers in Surgery|November 7, 2022
ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinomaChiyu Zhang, Honglin Hu, Ruizhen Huang, et al.
Frontiers in Physiology|August 5, 2021
Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury <i></i> Inhibition of NF-κB Activation and Inflammation in RatsGaode Zou, Zhiyu Zhou, Xiaoqing Xi, et al.
American Journal of Nephrology|October 18, 2014
MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in miceHonglin Hu, Wei Jiang, Xiaoqing Xi, et al.
European Journal of Pharmacology|September 28, 2019
Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathwayXiaoqing Xi, Cong Zou, Zhenfeng Ye, et al.
The Journal of Surgical Research|April 18, 2012
Protective effects of pioglitazone on renal ischemia-reperfusion injury in miceHonglin Hu, Cong Zou, Xiaoqing Xi, et al.
The Journal of Surgical Research|April 3, 2013
Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacityCong Zou, Honglin Hu, Xiaoqing Xi, et al.
Scientific Reports|December 1, 2023
Identification of differentially expressed circRNAs in prostate cancer of different clinical stages by RNA sequencingXing Wang, Ruizhen Huang, Juhui Yu, et al.
Frontiers in Pharmacology|August 22, 2018
Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy PathwayWenlin Chen, Xiaoqing Xi, Shuangyang Zhang, et al.
Frontiers in Immunology|June 29, 2023
Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltrationChiyu Zhang, Gaomin Huang, Jiale Yang, et al.
Pageof 15